2/12/2010

The National Marrow Donor Program chose North Carolina's Biologics to oversee inventory and distribution of Neupogen, a drug that boosts white blood cells, during a Phase III trial involving blood stem cell transplant patients with unrelated donors. The trial has been going on since 1997 and is expected to enroll 15,000 participants by 2012.

Related Summaries